Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Patent Profile: Helix BioMedix Announces Issuance of Patent for Antimicrobial Peptide

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Donald Zuhn -- Helix BioMedix, Inc. announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,407,940, which is directed to hexapeptides that exhibit antimicrobial activity against infections caused by a variety of pathogens. According to Helix Biomedix's statement, the '940 patent covers a family of hexapeptide antimicrobial agents, including the company's lead pre-clinical candidate HB1345, for use as broad spectrum topical anti-infectives. The Bothell, WA-based biopharmaceutical company noted that HB1345 will be initially developed for dermatological indications such as acne, rosacea, and atopic dermatitis, and then subsequently for the prevention of hospital acquired infections such...

Full post as published by Patent Docs on August 26, 2008 (boomark / email).